ATE210449T1 - Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards - Google Patents

Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Info

Publication number
ATE210449T1
ATE210449T1 AT92912078T AT92912078T ATE210449T1 AT E210449 T1 ATE210449 T1 AT E210449T1 AT 92912078 T AT92912078 T AT 92912078T AT 92912078 T AT92912078 T AT 92912078T AT E210449 T1 ATE210449 T1 AT E210449T1
Authority
AT
Austria
Prior art keywords
composition
myocardial reperfusion
reperfusion damage
reducing myocardial
adenosine
Prior art date
Application number
AT92912078T
Other languages
English (en)
Inventor
Mervyn B Forman
Edwin K Jackson
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE210449T1 publication Critical patent/ATE210449T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
AT92912078T 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards ATE210449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/704,058 US5206222A (en) 1991-05-22 1991-05-22 Methods for the reduction of myocardial reperfusion injury
PCT/US1992/002528 WO1992020346A1 (en) 1991-05-22 1992-03-26 Method and composition to reduce myocardial reperfusion injury

Publications (1)

Publication Number Publication Date
ATE210449T1 true ATE210449T1 (de) 2001-12-15

Family

ID=24827883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912078T ATE210449T1 (de) 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Country Status (7)

Country Link
US (1) US5206222A (de)
EP (1) EP0589964B1 (de)
JP (1) JPH06510751A (de)
AT (1) ATE210449T1 (de)
CA (1) CA2103458C (de)
DE (1) DE69232287T2 (de)
WO (1) WO1992020346A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
WO1999015184A1 (en) * 1997-09-22 1999-04-01 Item Development New method of treatment
EP1021195A1 (de) * 1997-10-07 2000-07-26 The Regents Of The University Of California Behandlung okklusiver peripheral-gefässkrankheiten und koronarkrankheiten mit kombinationen aus heparin und adenosin-a2-agonisten, oder mit adenosin
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
CN1344135A (zh) * 1999-03-23 2002-04-10 詹姆斯库克大学 器官的停止、保护和保存
US6368573B1 (en) * 1999-11-15 2002-04-09 King Pharmaceuticals Research And Development, Inc. Diagnostic uses of 2-substituted adenosine carboxamides
US6599283B1 (en) * 2001-05-04 2003-07-29 Cv Therapeutics, Inc. Method of preventing reperfusion injury
DE10258770B4 (de) * 2001-12-18 2005-02-10 F. Hoffmann-La Roche Ag Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen
AUPS312602A0 (en) * 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
US20060034941A1 (en) * 2002-12-23 2006-02-16 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery
AU2003291847B2 (en) * 2002-12-23 2010-12-02 Hibernation Therapeutics, A Kf Llc Organ preconditioning, arrest, protection, preservation and recovery
WO2005117910A2 (en) * 2004-05-26 2005-12-15 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
US20110076255A1 (en) * 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
JP5203214B2 (ja) * 2005-11-30 2013-06-05 イノテック ファーマシューティカルズ コーポレイション プリン化合物およびその使用方法
EP2079301B1 (de) 2006-05-29 2017-03-15 Hibernation Therapeutics, a KF LLC Verbesserte gewebeerhaltung
EP2139316B1 (de) * 2006-07-25 2015-03-18 Hibernation Therapeutics, a KF LLC Traumatherapie
WO2008106724A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
WO2008134740A1 (en) * 2007-04-30 2008-11-06 The Trustees Of The University Of Pennsylvania System and method of resuscitation of a mammal
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
AU2008280836A1 (en) * 2007-07-25 2009-01-29 Hibernation Therapeutics, A Kf Llc Improved organ protection, preservation and recovery
US20090218349A1 (en) * 2008-02-29 2009-09-03 Silgan Containers Corporation Vacuum container with protective features
MX2012007661A (es) 2010-01-11 2012-08-01 Inotek Pharmaceuticals Corp Combinacion, kit y metodo para reducir la presion intraocular.
US8476247B2 (en) 2010-03-26 2013-07-02 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans
CA2861009A1 (en) 2012-01-26 2013-08-01 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
AU2014239222A1 (en) 2013-03-15 2015-10-01 Inotek Pharmaceuticals Corporation Ophthalmic formulations
AU2014292826A1 (en) 2013-07-17 2016-02-04 Hibernation Therapeutics, A Kf Llc A method for treating infection, sepsis and injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
DE3781080T2 (de) * 1986-09-30 1992-12-24 Ciba Geigy Ag 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
EP0267878A1 (de) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-Cyclopentylsubstituierte Adeninderivate
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
US5206222A (en) 1993-04-27
EP0589964B1 (de) 2001-12-12
CA2103458C (en) 2000-11-14
WO1992020346A1 (en) 1992-11-26
DE69232287T2 (de) 2002-07-25
JPH06510751A (ja) 1994-12-01
CA2103458A1 (en) 1992-11-23
EP0589964A1 (de) 1994-04-06
DE69232287D1 (de) 2002-01-24
EP0589964A4 (en) 1994-05-25

Similar Documents

Publication Publication Date Title
ATE210449T1 (de) Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE3674308D1 (de) Biozide zusammensetzungund verfahren zur behandlung von wasser.
RU93048466A (ru) Применение бензотиофенов для профилактики и лечения остеопороза и фармацевтическая композиция на их основе
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
BR9304988A (pt) Composições auto-dispersáveis em água contendo organopolissiloxano e processo para o tratamento de madeira
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
ATE190840T1 (de) Zusammensetzung zur behandlung der parkinson- krankheit
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DE3576834D1 (de) Oberflaechlich behandeltes magnesium oder dessen legierungen und verfahren zum oberflaechenbehandeln.
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
ATE394104T1 (de) Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69113221D1 (en) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
EP1037918A4 (de) Verfahren und zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
RO92632A (ro) Compozitie farmaceutica sinergetica pentru tratamentul inflamatiilor pancreasului
UA50728C2 (uk) Спосіб стимуляції імунної системи за допомогою димеру лізоциму
DE69314022D1 (de) Derivate von 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranen
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
FI900372A7 (fi) Aryyli- ja heteroaryylietanoli-pyridyylialkyyliamiinit, menetelmä niiden valmistamiseksi ja niiden käyttö suoritusta edistävinä aineina eläimillä ja liikalihavuuden hoitoon käytettävinä aineina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee